The SELECT trial addressed this gap by enrolling individuals with overweight or obesity and established cardiovascular disease but without diabetes, demonstrating a 20% reduction in MACE with semaglutide
Avoid fast foods, processed foods, alcohol, spicy and acidic foods, etc
Supplement what is actually low
This selective information sharing has created a knowledge gap, leaving consumers unaware of potential risks
Gastrointestinal symptomssuch as nausea, vomiting, diarrhea, or changes in appetiteare among the most frequently reported
For people with diabetes, semaglutide improves glycemic control, with studies reporting an average HbA1c reduction of approximately 1.5% after six months, reflecting glucose-dependent insulin secretion and a lower risk of hypoglycemia